1. National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal 2013. 2013. https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781. Accessed Sep 2018.
2. National Institute for Health and Care Excellence (NICE). Encorafenib with binimetinib for treating advanced (unresectable or metastatic) BRAF V600 mutation-positive melanoma [ID923]:final appraisal document. 2019. https://www.nice.org.uk/guidance/ta562/documents/final-appraisal-determination-document. Accessed June 2019.
3. Office for National Statistics. Cancer Registration Statistics, England: 2016. 2018. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/final2016. Accessed Sep 2018.
4. Cancer Research UK. Skin cancer statistics: skin cancer incidence statistics. 2018. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/skin-cancer/incidence. Accessed Sep 2018.
5. Karimkhani C, Green AC, Nijsten T, Weinstock MA, Dellavalle RP, Naghavi M, et al. The global burden of melanoma: results from the Global Burden of Disease Study 2015. Br J Dermatol. 2017;177(1):134–40.